BookAdnan Aydiner, Abdullah İgci, Atilla Soran, editors.
Contents:
1. Biopsy techniques in non-palpable or palpable breast lesions
2. Evaluation of patients for metastases prior to primary therapy
3. Staging of breast cancer
4. Surgical treatment of early-stage breast cancer
5. Evaluation of axillary nodes
6. Breast reconstruction
7. Adjuvant systemic therapy: endocrine therapy
8. Adjuvant systemic chemotherapy for HER2-negative disease
9. Adjuvant therapy for HER2-positive early breast cancer
10. Post-mastectomy adjuvant radiotherapy (PMRT)
11. Adjuvant radiation therapy after peroperative chemotherapy
12. Breast-conserving therapy: hypofractionated and conventional whole-breast irradiation and accelerated partial-breast irradiation
13. Preoperative therapy for operable breast cancer
14. Neoadjuvant hormonal therapy in breast cancer
15. Systermic therapy for locally advanced breast cancer
16. Systemic therapy for inflammatory breast cancer
17. Surgical management of operable breast cancer after neoadjuvant systemic therapy
18. Surgical management of locally advanced breast cancer
19. Surgical management of inflammatory breast cancer
20. Occult primary breast cancer with axillary metastases
21. Breast cancer in older women
22. Breast cancer in young women (premenopausal breast cacner)
23. Male breast cancer
24. Breast cancer in pregnancy
25. Paget's disease of the breast
26. Phyllodes tumors of the breast
27. Nonepithelial malignancies of the breast
28. Surveillance of patients following primary therapy
29. Surgery for the primary tumor in patients with de novo stage IV breast cancer
30. Local-regional recurrence after breast-conservation treatment or mastectomy
31. Treatment of metastic breast cancer: chemotherapy
32. Treatment of metastatic breast cancer: chemotherapy
33. Treatment of HER2-overexpressing metastatic breast cancer
34. End-of-life considerations in patients with breast cancer
35. Angiogenesis inhibition in breast cancer
36. Tyrosine kinase inhibitors
37. Neurological metastases
38. Ocular metastases
39. Management of malignant pleural effusions in breast cancer
40. Management of discrete pulmonary nodules
41. Management of isolated liver metastasis
42. Bone-directed therapy and breast cancer: bisphosphonates, monoclonal antibodies, and radionuclides
43. The local management of bone metastases
44. A review of local and systemic therapy in breast cancer
45. Decision pathways in breast cancer management
46. Nursing care and management
47. Psychosocial adaptation during and after breast cancer
48. Breast cancer-related lymphedema (BCRL)
49. Reproductive issues in breast cancer
50. Onco-cardiology for breast cancer
Index.